The One World Doll Project, a subsidiary of One World Holdings, Inc. (OWOO), today released an interview with its founder, Trent T. Daniel, in which Daniel discusses the company’s recent national retail distribution deal with Hallmark stores and Wal-Mart Stores, Inc. (NYSE: WMT).

This interview provides shareholders, potential investors and other interested parties the opportunity to understand the details behind the company’s fall 2015 debut in over 2,900 Walmart stores across the nation.

View the video on the company website at http://oneworlddolls.com/investors.

Established in 2010 by Daniel and Stacey McBride-Irby, The One World Doll Project is committed to changing the retail landscape of the doll industry. The Prettie Girls! are a collection of fashion play dolls diverse in culture, interests and style.

For more information, visit www.oneworlddolls.com

Let us hear your thoughts: One World Holdings Message Board

Flexshopper, Inc. (OTCQB: FPAY) is a financial and technology company that provides consumers with a flexible and easy way to get furniture, electronics, appliances and other popular brand name goods with affordable weekly payments. The company’s unique personal shopping assistant platform allows consumers to utilize a patent pending lease-to-own (LTO) payment method to purchase a full selection of qualifying merchandise from some of the country’s most respected retail and e-commerce providers.

By leasing items within Flexshopper’s expansive LTO network, consumers can acquire the products they want without the need for a long-term commitment. Under the company’s model, the merchandise can be returned at any time with proper notice without penalty, or shoppers can continue to pay for one year and take ownership of the leased items.

According to a report by the Association of Progressive Rental Organizations, the LTO industry served approximately 4.8 million customers throughout North America in 2012, accounting for annual revenue of approximately $8.5 billion. This industry performance has provided Flexshopper with a formidable platform to realize strong financial growth in recent years. In the first quarter of 2015, the company recorded lease revenues of more than $3.6 million, marking a year-over-year increase of over $3.5 million.

“We are pleased with our lease originations in the first quarter,” Brad Bernstein, chief executive officer of Flexshopper, stated in a news release. “[W]e are excited to increase our lease originations on all of our channels which include in retail stores, online with our patent pending lease-to-own payment method and on our ecommerce marketplace.”

In March, Flexshopper secured a debt facility of up to $100 million and a $9.35 million equity raise from Middleman Partners, providing the company with the capital needed to promote accelerated growth through its LTO ecommerce marketplace and payment method in the coming months.

“This debt and financing increases our balance sheet strength and ensures that we are well positioned to execute our strategies of… positioning ourselves as the only LTO platform that can provide retailers and e-tailers with multiple digital channels to increase their sales with LTO consumers,” continued Bernstein.

With the persistent expansion of the LTO industry in recent years, Flexshopper is in a strong strategic position to continue improving its financial results in the future. For prospective investors, the company’s newly acquired capital could provide the means for accelerated growth and sustainable returns moving forward.

For more information, visit www.flexshopper.com

Car Monkeys Group, through CarMonkeys.com, is one of the largest and fastest growing online automotive parts distributors in the United States. By offering a complete selection of high quality used parts for a wide range of vehicle makes and models, the company provides its customers with an industry-leading shopping experience.

Using its proprietary part finder, the company makes it simple to find the perfect parts for nearly any vehicle among a network of hundreds of thousands of high quality used parts. Built upon a groundbreaking search and consolidation algorithm, the company’s search function helps consumers navigate issues surrounding part interchangeability to find the perfect part, even if it’s from a completely different vehicle. This allows Car Monkeys to effectively eliminate one of the primary limitations of many of its competitors’ parts networks, strategically positioning the company for continued market growth moving forward.

“The Car Monkeys brand has an established, reputable and expanding presence in the online used car space, and we intend to utilize this success as a platform for continued growth,” Mariusz Girt, chief executive officer of Car Monkeys, stated in a news release.

For consumers, the benefits of utilizing used automotive parts can be massive. According to a report by the Environmental Protection Agency, consumers purchasing used or reconditioned parts can save 50 percent or more, as compared to the cost of new parts. Utilizing recovered automobile parts is also beneficial from an environmental prospective. The North American automotive recycling industry saves an estimated 85 million barrels of oil annually that would otherwise be needed to make new or replacement auto parts.

Since being founded in 2010, Car Monkeys has emerged as a player in the multi-billion dollar automotive recycling industry. By consistently providing its customers with one of the industry’s best warrantees, the company has made significant strides in developing brand confidence and, as a result, opened the door for continued growth.

For prospective investors, Car Monkeys represents a growing brand in one of the country’s most consistently performing industry sectors. Look for the company to continue building on its established presence in the automotive industry moving forward.

Take a closer look at the company, or find that part you need, by visiting www.carmonkeys.com

Let us hear your thoughts: Car Monkeys Group Message Board

According to a report by the American Cancer Society, approximately 25 percent of the estimated 580,000 cancer-related deaths in 2013 were the result of gastrointestinal or digestive cancers. Exact Sciences Corp. (NASDAQ: EXAS), through the continued development and commercialization of Cologuard and related products, is committed to playing a role in substantially reducing this figure moving forward by targeting the complete eradication of colorectal cancer.

Approved by the FDA in August 2014, Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers. In a 10,000-patient clinical study, the company’s revolutionary test effectively diagnosed 92 percent of colon cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Because of this accurate cancer detection ability, Cologuard is currently included in the colorectal cancer screening guidelines of the American Cancer Society.

During the first quarter of 2015, Exact Sciences recorded strong growth for Cologuard, providing the company with a formidable platform for sustained increases in market share moving forward. In the period, 11,000 Cologuard tests were completed and the number of ordering physicians increased from 4,100 at the end of 2014 to 8,300 in the first three months of 2015. The company also expanded its sales team by 75 percent in order to promote continued development of the test’s existing physician network and commercial insurance coverage options.

“We are pleased with the strong launch trajectory of Cologuard,” Kevin Conroy, chairman and chief executive officer of Exact Sciences, stated in a news release. “Demand among patients and physicians and acceptance among commercial insurers is accelerating.”

Since the initial commercialization of Cologuard, Exact Sciences has recorded drastically amplified financial results. In the first quarter of 2015, the company reported total revenues of $4.3 million, a $4 million increase over the same period in 2014. In the coming months, the company will look to build on this development through persistent progress in expanding the test’s utilization rates.

For prospective shareholders, the early market success of Cologuard, as well as the company’s ongoing development of diagnostic tools targeting esophageal, pancreatic and lung cancers, makes Exact Sciences an intriguing investment opportunity moving forward.

For more information, visit www.exactsciences.com

One World Holdings, through its wholly-owned subsidiary, the One World Doll Project, recently announced the next phase of expansion for its acclaimed brand of multicultural fashion and play dolls. The highly anticipated Prettie Girls!™ Tween Scene collection will arrive in approximately 3,000 Walmart stores across the United States in October, providing the company with an opportunity to continue building on the success of its four original Prettie Girls! dolls.

“Our vision in developing the Prettie Girls! Tween Scene collection was to provide young girls with dolls that represent their individual backgrounds, stories, styles, goals and inspirations,” Trent T. Daniel, founder of OWOO, stated in a news release. “It is an honor to launch this new line, which endeavors to reflect America’s children, at Walmart, where America shops.”

The new collection will consist of pre-teen versions of the company’s original dolls, including all four of the Prettie Girls! characters, in addition to the introduction of two new personalities representing additional cultures and backgrounds. In total, the company’s new line will include African-American, Hispanic, South Asian, African, Asian and Caucasian dolls.

The Prettie Girls! were originally launched in 2010 by Daniel and Stacey McBride-Irby, a former designer for toy giant Mattel® who is widely regarded for her role in creating Mattel’s first African-American dolls. Since 2010, OWOO has received orders from a collection of major retailers, including Amazon, Walmart and Toys”R”Us. This increased presence has helped the company post improved financial results in recent months. In April, OWOO announced a 532 percent increase in annual year-over-year revenue in 2014, and the company’s management team expects continued growth moving toward the holiday season.

“It has already been a big year for us and as we continue to expand the Prettie Girls! brand across the nation, we expect to see even more sales performance as the 2015 Christmas season draws closer,” stated Joanne Melton, chief executive officer of OWOO.

According to the Toy Association, the domestic toy industry accounted for over $18 billion in revenue in 2014, with $2.32 billion attributed to the doll category. Through the release of the Prettie Girls! Tween Scene collection later this year, OWOO will be in a strong position to continue expanding upon its current share of the thriving market. For prospective investors, this announcement could foreshadow an extremely promising holiday season later this year.

For more information, visit www.oneworlddolls.com

Let us hear your thoughts: One World Holdings Message Board

Transgenomic, Inc. (NASDAQ: TBIO) is a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through progressive diagnostic technologies, such as its revolutionary ICE-COLD PCR™ (MX-ICP). Through this technology, the company provides more sensitive and accurate mutation detection without major costs or impact to current processes.

In May, Transgenomic built on the versatility of its MX-ICP platform through the launch of a novel epidermal growth factor receptor (EGFR) CLIA test for mutation detection in cancer patients, effectively opening the door for more informed diagnoses, better treatment decisions and ongoing patient monitoring moving forward. The first tests using this platform were for the detection of EGFR T790M mutations, which have been linked to patient resistance of current non-small cell lung cancer (NSCLC) treatment options.

“Launching our multiplexed ICE COLD-PCR-based CLIA mutation detection service for oncologists and their patients is a major milestone for Transgenomic and, we believe, an important advance for the field of precision medicine,” Paul Kinnon, president and chief executive officer of Transgenomic, stated in a news release. “The unsurpassed accuracy of MX-ICP and its ability to produce highly sensitive and accurate results from small amounts of almost any type of patient sample, especially liquid biopsies, allows broad use.”

MX-ICP has been shown effective in the detection of mutation with a range of biofluid samples – including blood, plasma, serum, urine, sputum and bronchial lavage – allowing for highly accurate, non-invasive diagnostics of all known and unknown mutations.

In recent months, Transgenomic has leveraged the considerable market for its diagnostic technologies and clinical and research services to record improved financial results. During the first quarter of 2015, the company’s net sales were recorded at a 4 percent year-over-year increase, with laboratory services sales increasing by over 30 percent for the same period.

“The company made good progress in the first quarter in strengthening our historical businesses while preparing for the imminent launch of our breakthrough technology: Multiplexed ICE-COLD PCR™,” continued Kinnon. “We achieved a double digit percentage increase in overall net sales excluding the divested Surveyor product line, including a robust 32 percent increase in the critical laboratory services segment.”

Moving forward, look for Transgenomic to continue building on its recent progress in order to maximize industry growth. For prospective investors, continued industry adoption of the company’s MX-ICP technology could provide ample opportunity to realize sustainable returns in the years to come.

For more information, visit www.transgenomic.com

Inergetics develops patented nutritional supplement products under a consortium of brands that serve the clinical nutrition, long-term care (senior care) and sports nutrition markets. Through its diverse line of products, Inergetics participates in a more than $104 billion global market with multi-billion dollar industry leaders like HerbaLife Ltd. (NYSE:HLF) and GNC Holdings, Inc. (NYSE:GNC).

Comprised of high-quality ingredients and proprietary formulations, Inergetics’ products are designed to improve overall health, physical recovery, athletic performance and quality of life for patients and consumers. Inergetics’ brand portfolio includes:

• Martha Stewart™ Essentials – a complete line of whole food-based supplements created specifically for women, developed under a partnership between Martha Stewart Essentials and Inergetics.
• Surgex Sports Nutrition’s – SURGEX® is a clinically proven, performance-enhancing formula designed to help athletes build lean muscle, increase energy and peak power, improve endurance, and quicken recovery time.
• Bikini Ready Lifestyle – an innovative natural ingredients formula built on nutraceutical science to help maintain weight; used by professional surfers Anastasia Ashley and Christa Alves.
• SlimTrim™ – a premium value diet supplement designed to support a healthy lifestyle and diet for weight loss. The SlimTrim formula features acai, resveratrol, green tea and other leading diet ingredients.
• OmEssentials® – line of scientifically advanced nutritional supplements designed to improve health and wellness of yoga practitioners and active individuals.
• Nulief™ CBD – cannabidiol (CBD)-based nutritional supplements.

Though Inergetics various products are similar to both HerbaLife and GNC in terms of product context, the companies’ sales strategy greatly differs. HerbaLife sells its products through independent distributors, while GNC products are sold online or one of the company’s numerous brick-and-mortar locations.

Inergetics brands are available both domestically and internationally at thousands of premier locations, including Bed Bath & Beyond (BBBY), PriceSmart (PSMT), Walgreens (WAG), Whole Foods (WFM), and a range of private retailers, as well as leading e-tailers such as Amazon (AMZN), Bodybuilding.com, CVS.com, Drugstore.com and more.

Inergetics, HerbaLife and GNC all participate in the growing global nutrition and supplements market breaks, which breaks into a variety of predominant and rapidly expanding categories. According to Persistence Market Research analysis, the global sports nutrition market alone, just one of the subcategories in which Inergetics participates, will achieve CAGR of 9% between 2013 and 2019, reaching $37.7 billion by the end of the seven-year spread.

Inergetics continues to expand its distribution network as it seeks deeper penetration in the global nutrition and supplements market, taking advantage of its diverse product line. In an earlier news release, the company noted its increasing strength, particularly in the Midwest, gaining momentum from growing demand in the health and wellness category.

For more information, visit www.inergetics.com

Let us hear your thoughts below:

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials focused on the treatment and diagnosis of cancer. The company’s lead immunotherapy candidate, bavituximab, has been granted fast track designation by the U.S. Food and Drug Administration for the treatment of second-line non-small lung cancer and is currently in phase III development for this indication. Bavituximab is also being evaluated for several solid tumor indications, including non-small cell lung cancer, rectal cancer and advanced melanoma.

“These new trials represent large market opportunities for the bavituximab clinical program that can add significant value,” Steven King, president and chief executive officer of Peregrine, stated in a news release. “[W]e believe we are setting the stage for many significant value driving events through 2015 and into 2016.”

Through its wholly-owned subsidiary, Avid Bioservices, Peregrine differentiates itself from competitors by offering in-house cGMP manufacturing capabilities, allowing the company to provide development and biomanufacturing services to support the needs of its clinical trials, as well as those of outside customers. In December, the company announced a substantial expansion to Avid’s current manufacturing capacity through the construction of a state-of-the-art 40,000 square foot biotechnology facility located adjacent to the company’s current campus. With this new facility, which is anticipated to be ready for cGMP production of biotechnology products next month, the company will be better equipped to meet the growing needs of Avid’s existing and future clients, as well as the expected commercialization of bavituximab.

“We are very pleased with the rapid progress by which this expansion is advancing as this is a key component to further demonstrating Avid as a leading provider of high quality biotechnology contract manufacturing services,” continued King. “The design and the features that we have employed in this expansion will truly be an integral part to the future growth of this unique part of our business.”

Moving forward, Peregrine will look to complete enrollment of its 600 patient phase III clinical trial of bavituximab, which is designed to evaluate the safety, tolerability and efficacy of the candidate as a second-line treatment in patients with non-squamous, non-small cell lung cancer. Look for the company to continue making strides toward the planned commercialization of bavituximab in the years to come, providing significant opportunity for sustainable shareholder returns along the way.

For more information, visit www.peregrineinc.com

Design and engineering firm Galenfeha, Inc. (OTC: GLFH) has extended its reach into the oil and gas industry by providing advanced stored energy solutions to U.S. oil and gas producer BHP Billiton (NYSE: BHP).

In addition to chemical injection systems, Galenfeha designs, manufactures and markets a complete line of patent pending, microprocessor-controlled battery systems specifically designed for oil and gas measurement, automation and production.

BHP Billiton will incorporate Galenfeha’s proprietary CDMA/satellite asset location and tracking technology in its battery systems. This technology is field proven and currently utilized by six of the largest hydrocarbon producers in the United States.

As Galenfeha further penetrates the energy industry, the company is rapidly emerging as the premier alternative stored energy supplier in North America.

“This is an incredibly exciting time for our company. From inception, Galenfeha has been diligently pursuing this level of cooperative involvement among energy producers. The opportunity to assist the highly esteemed, global powerhouse firm BHP Billiton is an enormous honor. Our team is prepared for this responsibility and I am delighted to announce this development to our shareholders,” Lucien Marioneaux, Jr., president and chief executive officer of Galenfeha, stated in the news release.

For more information, visit www.galenfeha.com

Let us hear your thoughts: Galenfeha, Inc. Message Board

Already home to over 200 different unified communications focused clients, who rely on the company for robust end-to-end solutions that seamlessly span the widest range of audio input devices, from POTS (plain old telephone service), to two-way and iDEN (TDMA-based digital wireless standard invented by Motorola with integrated push-to-talk) radio networks, Cleartronic’s (OTC: CLRI) wholly owned VoiceInterop subsidiary continues to act as a one-stop-shop for government agencies and large commercial enterprises. VoiceInterop’s family of AudioMate360 IP voice gateway devices, along with cutting-edge AudioMate Software and HTTP-based AudioMate Configuration Console for managing hundreds of AudioMate360 devices at once, constitute an open-ended, device-agnostic architecture that is capable of handling everything from unified real-time voice communications, to executing programs and transferring data.

Whereas most solutions in the sector today are highly hardware-centric, VoiceInterop’s subscription-based X-Stream Access service takes a completely different approach, allowing users to leverage existing IT and telecom infrastructure in order to create a platform that enables any authorized user to securely communicate using any radio, telephony, or PC device, irrespective of frequency, manufacturer, or system-based protocols. This universalized approach also allows VoiceInterop to take a standards-based software development approach, bundling feature-rich middleware applications together which third party system integrators can resell.

One of the primary endpoints of such an approach is that these kinds of unified communications (UC) solutions can be executed in a highly scalable fashion, meaning that they can be expanded or contracted with ease to meet the size or changing dynamics of a given client. Whether the client is a small/local government agency, or a sprawling multinational with personnel all over the globe, they can rapidly implement a solution using the company’s easy to deploy software, or have VoiceInterop handle the details. The other major end point with such solutions is the associated cost-effectiveness that only such tailored architectures provide, making it so even government agencies on a tight budget can migrate to a truly 21st century UC solution without breaking the bank.

One of VoiceInterop’s strongest client sectors has and continues to be airports, an environment where real-time UC can mean the difference between life and death, both for emergency service teams, and flight crew/passengers. When a wide-body jet with over a hundred passengers crashes just shy of the runway at one of the world’s busiest international airports, response time and the ability to coordinate field personnel, as well as said personnel’s ability to communicate with one another while out in the field, is of paramount importance. When the unthinkable happens, it is too late to start worrying about a comprehensive UC solution that is hassle-free and can provide the kind of rock-solid, guaranteed response capabilities needed to avert further catastrophe.

In such an event, air traffic controllers in the tower need to be able to simply pick up a phone and instantly connect with first responders at the crash site, as well as other airport personnel. Unfortunately, many airports around the country still are woefully lacking when it comes to a robust UC solution, and so VoiceInterop has been helping clients, like Orlando’s Sanford International Airport, with custom installations and ongoing support of secure, interoperable UC solutions. Other VoiceInterop clients include such well-known airports as Dulles, Green Bay, Omaha, Reagan, and West Palm Beach.

The latest client to hop on board is Edmonton Regional Airports Authority, which manages emergency response at both Edmonton International and the Villeneuve Airport. The company is tasked with providing its site-customized VoiceInterop Crash Phone system in both cases, a system utilizing the company’s proprietary software and leveraging both standard commercial communications devices and existing infrastructure, like IP telephones, two-way radios, and the overhead paging/alert systems, all organized and finely tuned to meet the specific needs of each facility’s personnel.

Moreover, because the system architectures are so highly scalable and built around the software as the real backbone for connectivity, the VoiceInterop Crash Phone systems installed at these facilities can grow as the locations do, allowing for cheap, easy, and effective changes to be made in the future, with system upgrades completed simply by making minor alterations to the software environment. It’s easy to see why airports and emergency first responders and agencies like fire and rescue, as well as law enforcement, trust Cleartronic to provide mission-critical UC solutions, given the low cost, broad-spectrum capability, and easy scalability they provide.

Take a closer look at the company by visiting www.cleartronicinc.com

Let us hear your thoughts: Cleartronic, Inc. Message Board